These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 16019681

  • 1. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
    Kahraman G, Krepler K, Franz C, Ries E, Maar N, Wedrich A, Rieger A, Dejaco-Ruhswurm I.
    Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
    [Abstract] [Full Text] [Related]

  • 2. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 4. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R.
    Ophthalmic Epidemiol; 2008 Jan; 15(4):264-71. PubMed ID: 18780260
    [Abstract] [Full Text] [Related]

  • 5. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
    Esposito S, Porta A, Bojanin J, Gualtieri L, Cesati L, Vismara E, Principi N.
    Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
    [Abstract] [Full Text] [Related]

  • 6. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK.
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR, Jabs DA.
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [Abstract] [Full Text] [Related]

  • 8. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
    Mihăilescu R, Arama V, Paraschiv S, Streinu-Cercel A, Oţelea D, Munteanu D, Iosipenco M, Chiotan C, Benea OE, Mărdărescu M, Rădulescu M, Hristea A, Ungurianu R, Aramă SS, Cercel AS, Călin R, Băicuş C.
    Rom J Intern Med; 2008 Dec; 46(4):305-11. PubMed ID: 19480296
    [Abstract] [Full Text] [Related]

  • 9. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 10. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B, Lisić M, Kniewald T, Ugrinović N, Begovac J.
    Lijec Vjesn; 2005 Oct; 127(5-6):123-8. PubMed ID: 16281473
    [Abstract] [Full Text] [Related]

  • 11. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Rudent A, Lantz O, Lecointe D, Furlan V, Delfraissy JF, Offret H.
    J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
    [Abstract] [Full Text] [Related]

  • 12. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM, Calabrò ML, De Rossi A, Aversa SM, Barbierato M, Trevenzoli M, Gasperini P, Zanchetta M, Cadrobbi P, Monfardini S, Chieco-Bianchi L.
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [Abstract] [Full Text] [Related]

  • 13. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
    Martin BK, Ricks MO, Forman MS, Jabs DA, Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Clin Infect Dis; 2007 Apr 01; 44(7):1001-8. PubMed ID: 17342657
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
    Shah SU, Kerkar SP, Pazare AR.
    Br J Ophthalmol; 2009 Jan 01; 93(1):88-90. PubMed ID: 18952644
    [Abstract] [Full Text] [Related]

  • 15. [Examination of the posterior eye segment during HIV infection: what is new?].
    Guex-Crosier Y.
    Klin Monbl Augenheilkd; 1999 May 01; 214(5):317-20. PubMed ID: 10420376
    [Abstract] [Full Text] [Related]

  • 16. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
    Kuo IC, Kempen JH, Dunn JP, Vogelsang G, Jabs DA.
    Am J Ophthalmol; 2004 Sep 01; 138(3):338-46. PubMed ID: 15364214
    [Abstract] [Full Text] [Related]

  • 17. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C, RESTIMOP study team.
    AIDS; 2001 Jan 05; 15(1):23-31. PubMed ID: 11192865
    [Abstract] [Full Text] [Related]

  • 18. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS, Patel A.
    Indian J Ophthalmol; 2002 Mar 05; 50(1):29-33. PubMed ID: 12090084
    [Abstract] [Full Text] [Related]

  • 19. CMV after HAART.
    Posit Aware; 1998 Mar 05; 9(5):18, 23. PubMed ID: 11365888
    [Abstract] [Full Text] [Related]

  • 20. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
    Kappel PJ, Charonis AC, Holland GN, Narayanan R, Kulkarni AD, Yu F, Boyer DS, Engstrom RE, Kuppermann BD, Southern California HIV/Eye Consortium.
    Ophthalmology; 2006 Apr 05; 113(4):683.e1-8. PubMed ID: 16581428
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.